以甘露糖化脂质体配制的全寄生虫恶性疟原虫血液期抗原有高度免疫原性(小鼠实验)
研究用免疫磁珠法去除感染恶性疟原虫的人红细胞膜,将所得全寄生虫血液期抗原构建为表面修饰甘露糖的脂质体,比较新鲜制备与冻干脂质体疫苗在小鼠中的免疫原性。接种后脂质体诱导对人红细胞抗体反应显著较低,但对寄生虫抗原产生强效的跨株和跨种细胞免疫应答。
要点
- 全寄生虫血液期抗原脂质体疫苗诱导对人红细胞抗体反应显著较低。
- 该疫苗诱导对寄生虫抗原强效的跨株和跨种细胞免疫应答。
- 数据支持将恶性疟原虫脂质体疫苗推进至临床研究。
核心结论
- 全寄生虫血液期抗原甘露糖化脂质体疫苗在小鼠中诱导对人红细胞抗体反应显著较低,但对寄生虫抗原产生强效的跨株和跨种细胞免疫应答,支持推进至临床研究。
研究设计与样本
- 研究采用免疫磁珠法去除感染恶性疟原虫的人红细胞膜以制备全寄生虫血液期抗原,并构建表面修饰甘露糖以靶向抗原提呈细胞的脂质体。
- 在小鼠中比较新鲜制备与冻干脂质体疫苗的免疫原性。
主要发现
- 接种后脂质体诱导对人红细胞抗体反应显著较低。
- 脂质体诱导对寄生虫抗原强效的跨株和跨种细胞免疫应答。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The development of a blood-stage malaria vaccine has largely focused on the subunit approach. However, the limited success of this strategy, mainly due to antigenic polymorphism and the failure to maintain potent parasite-specific immune responses, indicates that other approaches must be considered. Whole parasite (WP) vaccines offer many advantages over sub-units; they represent every antigen on the organism, thus limiting the effects of antigenic polymorphism, and similarly they compensate for individual Immune-Response (Ir) gene-regulated non-responsiveness to any particular antigen. From a development perspective, they negate the need to identify and compare the relative efficacies of individual candidate antigens. WP vaccines induce protective immunity that is largely cell-mediated. However, WP blood-stage vaccines present a number of challenges for the development pathway. Key issues are cryopreservation and storage and the possible induction of antibodies against red blood cell surface antigens, even if the parasites are grown in blood group O, Rh negative blood. Here, we used a novel adaptation of an immunomagnetic method from STEMCELL™ Technologies to remove the red cell membranes from human red blood cells parasitized with P. falciparum. We then used these antigens to construct liposomes which were modified to present mannose on their membrane to target the liposome to antigen presenting cells. We then compared the immunogenicity of freshly prepared and lyophilized liposome vaccines. Following vaccination of mice, liposomes induced significantly lower antibody responses to human red cells but potent strain- and species-transcending cell-mediated immune responses to parasite antigens. These data support transitioning the P. falciparum liposomal vaccine into clinical studies.
引用
- Ssemaganda A, Giddam AK, Low LM, et al. Mannosylated liposomes formulated with whole parasite P. falciparum blood-stage antigens are highly immunogenic in mice. Vaccine. 2019. PMID: 31866187. doi:10.1016/j.vaccine.2019.11.063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。